Noninvasive MRI-SERS Imaging in Living Mice Using an Innately Bimodal Nanomaterial
Source abstract
Abstract
We report a novel nanomaterial (AuMN-DTTC) that can be used as a bimodal contrast agent for in vivo magnetic resonance imaging (MRI) and Raman spectroscopy. The probe consists of MRI-active superparamagnetic iron oxide nanoparticles, stably complexed with gold nanostructures. The gold component serves as a substrate for a Raman active dye molecule to generate a surface-enhanced Raman scattering (SERS) effect. The synthesized probe produces T2 weighted contrast and can be used as a SERS active material both in silico (in aqueous solution) and in vivo. A quantitative assessment of T2 relaxation times was obtained using multiecho MRI analysis. The T2 relaxation times of AuMN-DTTC and MN (dextran-coated iron oxide nanoparticles) were 29.23 + 1.45 and 31.58 + 1.7 ms, respectively. The SERS signature of AuMN-DTTC revealed peaks at 508, 629, 782, 844, 1080, 1108, 1135, and 1242 cm(-1). Intramuscular administration of the probe resulted in a decrease of the T2 relaxation time of muscle from 33.4 + 2.5 to 20.3 + 2.2 ms. SERS peaks were observed at 508, 629, 782, 844, 1080, 1108, 1135, and 1242 cm(-1), consistent with the in silico results. Our studies illustrate for the first time the design and in vivo application of a contrast agent, whose component modalities include MRI and SERS. The value of this agent lies in its innately bimodal nature and its application in vivo for molecular imaging applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Gold and Silver Nanoparticles Synthesis and Applications · Nanocluster Synthesis and Applications · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Molecular Imaging Laboratory, MGH/MIT/HMS Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129, United States
Agilton Inc., 15 Cabot Rd, Woburn Massachusetts 01801, United States
School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts 02138, United States
Harvard-MIT Division of Health Sciences and Technology (HST)
Center for Materials Science & Engineering
References (49)
Show source-provided references
1. Bulte J. W. M. · NMR Biomed. · 2004 · 17 · 48410.1002/nbm.924 ↗
2. Alivisatos P. · Nat. Biotechnol. · 2004 · 22 · 4710.1038/nbt927 ↗
3. Ferrari M. · Nat. Rev. Cancer · 2005 · 5 · 16110.1038/nrc1566 ↗
4. Niemeyer C. M. · Angew. Chem., Int. Ed. · 2001 · 40 · 412810.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S ↗
5. Yigit M. V. · ChemBioChem · 2007 · 8 · 167510.1002/cbic.200700323 ↗
6. Medarova Z. · Nat. Med. · 2007 · 13 · 37210.1038/nm1486 ↗
7. Sun C. · Nanomedicine · 2008 · 3 · 49510.2217/17435889.3.4.495 ↗
8. Shi M. · Adv. Funct. Mater. · 2009 · 19 · 168910.1002/adfm.200801271 ↗
9. Liu J. · Angew. Chem., Int. Ed. · 2006 · 45 · 9010.1002/anie.200502589 ↗
10. Josephson L. · Angew. Chem., Int. Ed. · 2001 · 40 · 320410.1002/1521-3773(20010903)40:17<3204::AID-ANIE3204>3.0.CO;2-H ↗
11. Patra, C. R.; Bhattacharya, R.; Mukhopadhyay, D.; Mukherjee, P.Fabrication of Gold Nanoparticles for Targeted Therapy in Pancreatic Cancer.Adv. Drug Delivery Rev. 2009, not supplied.10.1016/j.addr.2009.11.007 ↗
12. Peer D. · Nat. Nanotechnol. · 2007 · 2 · 75110.1038/nnano.2007.387 ↗
13. Boisselier E. · Chem. Soc. Rev. · 38 · 175910.1039/b806051g ↗
14. Berry C. C. · J. Phys. D: Appl. Phys. · 2003 · 36 · R19810.1088/0022-3727/36/13/203 ↗
15. Sanles-Sobrido M. · J. Am. Chem. Soc. · 2009 · 131 · 269910.1021/ja8088444 ↗
16. Kim K. · ACS Appl. Mater. Interfaces · 2010 · 2 · 187210.1021/am1002074 ↗
17. Spuch-Calvar M. · J. Phys. Chem. C · 2008 · 113 · 337310.1021/jp810470n ↗
18. Bouchard L. S. · Proc. Natl. Acad. Sci. U.S.A. · 2009 · 106 · 408510.1073/pnas.0813019106 ↗
19. Xu Z. · J. Am. Chem. Soc. · 2007 · 129 · 869810.1021/ja073057v ↗
20. Glaus C. · Bioconjugate Chem. · 2010 · 21 · 71510.1021/bc900511j ↗
21. Xie J. · Biomaterials · 2010 · 31 · 301610.1016/j.biomaterials.2010.01.010 ↗
22. Harisinghani M. G. · N. Engl. J. Med. · 2003 · 348 · 249110.1056/NEJMoa022749 ↗
23. Connor E. E. · Small · 2005 · 1 · 32510.1002/smll.200400093 ↗
24. Merchant B. · Biologicals · 1998 · 26 · 4910.1006/biol.1997.0123 ↗
25. Root S. W. · Cancer · 1954 · 7 · 85610.1002/1097-0142(195409)7:5<856::AID-CNCR2820070506>3.0.CO;2-A ↗
26. Sun I. C. · Chemistry · 2009 · 15 · 1334110.1002/chem.200902344 ↗
27. Popovtzer R. · Nano Lett. · 2008 · 8 · 459310.1021/nl8029114 ↗
28. Liu J. · J. Am. Chem. Soc. · 2003 · 125 · 664210.1021/ja034775u ↗
29. Liu J. · Anal. Chem. · 2004 · 76 · 162710.1021/ac0351769 ↗
30. Evgenov N. V. · Nat. Med. · 2006 · 12 · 14410.1038/nm1316 ↗
31. Medarova Z. · Cancer Res. · 2009 · 69 · 118210.1158/0008-5472.CAN-08-2001 ↗
32. Sosnovik D. E. · Curr. Opin. Biotechnol. · 2007 · 18 · 410.1016/j.copbio.2006.11.001 ↗
33. Doering W. E. · Anal. Chem. · 2003 · 75 · 617110.1021/ac034672u ↗
34. Kneipp K. · Phys. Rev. Lett. · 1997 · 78 · 166710.1103/PhysRevLett.78.1667 ↗
35. Michaels A. M. · J. Am. Chem. Soc. · 1999 · 121 · 993210.1021/ja992128q ↗
36. Qian X. · Nat. Biotechnol. · 2008 · 26 · 8310.1038/nbt1377 ↗
37. Campion A. · Chem. Soc. Rev. · 1998 · 27 · 24110.1039/a827241z ↗
38. Moore B. D. · Nat. Biotechnol. · 2004 · 22 · 113310.1038/nbt1003 ↗
39. Nie S. M. · Science · 1997 · 275 · 110210.1126/science.275.5303.1102 ↗
40. Kneipp K. · Chem. Rev. · 1999 · 99 · 295710.1021/cr980133r ↗
41. Stoeva S. I. · J. Am. Chem. Soc. · 2005 · 127 · 1536210.1021/ja055056d ↗
42. Panyam J. · Adv. Drug Delivery Rev. · 2003 · 55 · 32910.1016/S0169-409X(02)00228-4 ↗
43. Mirkin C. A. · Nature · 1996 · 382 · 60710.1038/382607a0 ↗
44. Storhoff J. J. · J. Am. Chem. Soc. · 1998 · 120 · 195910.1021/ja972332i ↗
45. Perez J. M. · Nat. Biotechnol. · 2002 · 20 · 81610.1038/nbt720 ↗
46. Perez J. M. · J. Am. Chem. Soc. · 2002 · 124 · 285610.1021/ja017773n ↗
47. Tsourkas A. · Angew. Chem., Int. Ed. · 2004 · 43 · 239510.1002/anie.200352998 ↗
48. Yigit M. V. · Bioconjugate Chem. · 2008 · 19 · 41210.1021/bc7003928 ↗
49. Medarova Z. · Nat. Protocols · 2006 · 1 · 42910.1038/nprot.2006.63 ↗